An Open Label, Single Dose, Microdialysis and Pharmacokinetic Study of TR-701 [DA 7218] in Normal Healthy Adults

Trial Profile

An Open Label, Single Dose, Microdialysis and Pharmacokinetic Study of TR-701 [DA 7218] in Normal Healthy Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Sep 2017

At a glance

  • Drugs Tedizolid (Primary)
  • Indications Gram-positive infections; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors Trius Therapeutics
  • Most Recent Events

    • 12 Oct 2011 Actual end date (March 2009) added as reported by ClinicalTrials.gov.
    • 12 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 06 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top